![]() Zuo disclosed that the team has carried out 80 such cell transplanting operations so far, and plans to start testing the method later this year. ORCID provides an identifier for individuals to use with their name as they engage in research, scholarship, and innovation activities. The paper says that lung tissue repair and pulmonary function enhancement were observed in patients 3-12 months after cell transplantation. However, identifying lung stem/progenitor cells with regenerative capacity and utilizing them to reconstruct functional tissue provides one of the biggest hopes to reverse the damage and cure such diseases. Traditional medicine can only slow down the fibrosis of lung tissues. The research indicates a promising future for regenerative medicine, noted Jun Wu, a professor at the University of Texas Southwestern Medical Center and Liu Guanghui, a researcher with the Institute of Biophysics under Chinese Academy of Sciences.Īccording to the paper, irreversible destruction of bronchi and alveoli can lead to multiple incurable lung diseases. The team’s work showed that functional adult human lung structures can be reconstituted by the method, which could become a mature regenerative therapeutic strategy in the near future, according to Tongji University. Xuejiao Fan, Yunfeng Liu, Jun Tao, Yingying Liu, Kang Li, Zhenwei Ling. Founded by the most influential entrepreneurs in China, including Jack Ma of Alibaba, David Yu of Focus Media, Liu YongHao of New Hope, Shi YuZhu of. The research by Professor Zuo Wei’s team at Tongji University School of Medicine has been recently published in the science journal Protein & Cell. Neng-Bin Chang, Xing Liu, Jia-Ying Xu, Dong Liu, Cong-Cong Shi, Wen-Yi Zhang. YunFeng Capital 2,455 followers on LinkedIn. ![]() Chinese scientists take the world’s lead in making regeneration of human lung tissues come true by orthotopic transplantation of tissue-specific stem/progenitor cells, China News reported on Feb.
0 Comments
Leave a Reply. |